TrpM4 channel in spinal cord injury
TrpM4 通道在脊髓损伤中的作用
基本信息
- 批准号:9249120
- 负责人:
- 金额:$ 33.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAgonistAstrocytesBindingBrain Hypoxia-IschemiaCSPG3 geneCationsCell VolumesCellsCicatrixComplexDataDefense MechanismsEdemaFibrinogenGeneticGlutamate ReceptorGoalsHourImpairmentIn SituInflammationInjectableInjection of therapeutic agentInjuryInterleukin-6Ion ChannelIschemiaKnockout MiceLesionMembraneModelingMolecularMorphologyMusNobel PrizeNormal CellPerfusionPhenotypePlayPreventionProtein IsoformsRehabilitation therapyReplacement TherapyRestRoleSiteSpinal CordSpinal Cord ContusionsSpinal cord injuryStimulusSwellingSystemTestingTherapeuticTimeTissuesTraumaWaterWorkaquaporin 4aquaporin 5astrogliosisaxon growthaxon regenerationcytotoxiceffective therapyexperimental studyimproved outcomeinflammatory markerinjury and repairknockout genenovelparticlepassive transportpreventpublic health relevancereceptorwater channel
项目摘要
DESCRIPTION (provided by applicant): Reactive astrogliosis after spinal cord injury (SCI) serves as a critical defense mechanism, but it also can be detrimental, causing swelling that leads to ischemia, and formation of a glial scar that inhibits axonal regeneration. Astrogliosis can be prevented by deleting aquaporin (Aqp) 4, but this too can be detrimental, since a glial scar is essential for restricting inflammation and lesion size. Therefore, down-modulation of astrogliosis and of Aqp4, but not total inhibition, are important therapeutic goals. Aqp channels passively transport H2O across membranes, with the amount of H2O transported determined by the osmotic gradient. The molecular mechanisms by which osmotic gradients are regulated in order to drive the flux of H2O are poorly understood, but likely involve ion channels. In resting astrocytes, Aqp4 physically co-associates with transient receptor potential (Trp) V4, a non-selective cation channel, with the assembled molecular complex being required for normal cell volume control. We discovered that the molecular mechanism by which H2O is handled undergoes a fundamental change when astrocytes become activated. Following SCI, the partner for Aqp4 co-association switches from TrpV4 to TrpM4, with molecular experiments showing that TrpM4 co-associates preferentially with Aqp4-M23, the isoform that assembles into 'orthogonal arrays of particles' that are associated with high rates of H2O transport. This switch provides an opportunity to down-modulate Aqp4-M23 preferentially by inhibiting TrpM4, and thereby favorably influence astrogliosis without directly or completely inhibiting Aqp4. In this competitive renewal, we will use a unique model involving fibrinogen injection into the spinal cord to study reactive astrogliosis in situ. We propose 3 Specific Aims (SA) to expand on our novel preliminary data on the role of TrpM4 in regulating Aqp4 and reactive astrogliosis. DESCRIPTION: In Specific Aim (SA) 1, we will test the hypothesis that TrpM4 deletion will favorably influence astrogliosis and astrocyte swelling. In SA2, we will test the hypothesis that Aqp4 and TrpM4 physically co-associate to form an integral molecular complex for the control of H2O transport in reactive astrocytes. In SA3, we will test the hypothesis that TrpM4 activation osmotically drives the flux of water via Aqp4 in reactive astrocytes. Each hypothesis in each aim is supported by robust preliminary data.
描述(由申请人提供):脊髓损伤(SCI)后的反应性星形胶质细胞增生是一种重要的防御机制,但它也可能是有害的,引起肿胀,导致缺血,并形成胶质瘢痕,抑制轴突再生。星形胶质细胞增生可以通过删除水通道蛋白(Aqp)4来预防,但这也可能是有害的,因为胶质瘢痕对于限制炎症和病变大小至关重要。因此,下调星形胶质细胞增生和Aqp 4,而不是完全抑制,是重要的治疗目标。Aqp通道被动地跨膜转运H2O,转运的H2O量由渗透梯度决定。调节渗透梯度以驱动H2O通量的分子机制知之甚少,但可能涉及离子通道。在静息星形胶质细胞中,Aqp 4与瞬时受体电位(Trp)V4(一种非选择性阳离子通道)物理共缔合,其中组装的分子复合物是正常细胞体积控制所需的。我们发现,当星形胶质细胞被激活时,处理H2O的分子机制发生了根本性的变化。SCI后,Aqp 4共缔合的伴侣从TrpV 4切换到TrpM 4,分子实验表明TrpM 4优先与Aqp 4-M23共缔合,Aqp 4-M23是组装成与H2O高速率转运相关的“正交颗粒阵列”的同种型。这种开关提供了通过抑制TrpM 4优先下调Aqp 4-M23的机会,从而有利地影响星形胶质细胞增生而不直接或完全抑制Aqp 4。在这个竞争性的更新,我们将使用一个独特的模型,涉及纤维蛋白原注射到脊髓原位研究反应性星形胶质细胞增生。我们提出了3个具体目标(SA),以扩大我们的新的初步数据的作用TrpM 4在调节Aqp 4和反应性星形胶质细胞增生。描述:在特定目标(SA)1中,我们将检验TrpM 4缺失将有利地影响星形胶质细胞增生和星形胶质细胞肿胀的假设。在SA 2中,我们将检验Aqp 4和TrpM 4物理共缔合以形成用于控制反应性星形胶质细胞中的H2O转运的完整分子复合物的假设。在SA 3中,我们将测试TrpM 4激活在反应性星形胶质细胞中通过Aqp 4逆向驱动水通量的假设。每个目标中的每个假设都得到了可靠的初步数据的支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vladimir Gerzanich其他文献
Vladimir Gerzanich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vladimir Gerzanich', 18)}}的其他基金
Sur1-Trpm4 regulation of the pro-inflammatory astrocytic secretome in EAE
Sur1-Trpm4 对 EAE 中促炎星形细胞分泌组的调节
- 批准号:
10544775 - 财政年份:2020
- 资助金额:
$ 33.58万 - 项目类别:
Sur1-Trpm4 regulation of the pro-inflammatory astrocytic secretome in EAE
Sur1-Trpm4 对 EAE 中促炎星形细胞分泌组的调节
- 批准号:
10341098 - 财政年份:2020
- 资助金额:
$ 33.58万 - 项目类别:
Sur1-Trpm4 regulation of the pro-inflammatory astrocytic secretome in EAE
Sur1-Trpm4 对 EAE 中促炎星形细胞分泌组的调节
- 批准号:
9885240 - 财政年份:2020
- 资助金额:
$ 33.58万 - 项目类别:
Role of TRP channels in secondary injury after brain trauma
TRP通道在脑外伤继发性损伤中的作用
- 批准号:
8501703 - 财政年份:2011
- 资助金额:
$ 33.58万 - 项目类别:
Role of TRP channels in secondary injury after brain trauma
TRP通道在脑外伤继发性损伤中的作用
- 批准号:
8233874 - 财政年份:2011
- 资助金额:
$ 33.58万 - 项目类别:
Role of TRP channels in secondary injury after brain trauma
TRP通道在脑外伤继发性损伤中的作用
- 批准号:
8320107 - 财政年份:2011
- 资助金额:
$ 33.58万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 33.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 33.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 33.58万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 33.58万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 33.58万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 33.58万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 33.58万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 33.58万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 33.58万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 33.58万 - 项目类别: